Phase II Study of a Non-platinum-containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab (PPB) as Initial Therapy for Patients with Advanced Lung Adenocarcinomas

HYPOTHESIS: Many patients with lung cancers cannot receive platinum-containing regimens due to co-morbid medical conditions. We designed the PPB regimen of paclitaxel, pemetrexed, and bevacizumab to maintain or improve outcomes while averting the unique toxicities of platinum-based chemotherapies. M...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Thorac Oncol
Главные авторы: Pietanza, Catherine M., Hellmann, Matthew D., Fiore, John J., Smith-Marrone, Stephanie, Basch, Ethan M., Schwartz, Lawrence H., Ginsberg, Michelle S., Shouery, Marwan, Newman, Samantha K., Shaw, Mary, Rogak, Lauren J., Lash, Alex, Hilden, Patrick, Kris, Mark G.
Формат: Artigo
Язык:Inglês
Опубликовано: 2016
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4877255/
https://ncbi.nlm.nih.gov/pubmed/26964771
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2016.02.018
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы